ArticleFrontiers in immunology2026

Neoadjuvant chemoimmunotherapy versus chemoradiotherapy for esophageal squamous cell carcinoma: a multicenter cohort study.

Yixiang Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.